anti-V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1) Antibodies

VTCN1 encodes a protein belonging to the B7 costimulatory protein family. Additionally we are shipping VTCN1 Proteins (40) and VTCN1 Kits (14) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
VTCN1 242122 Q7TSP5
VTCN1 79679 Q7Z7D3
VTCN1 295322 Q501W4
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-VTCN1 Antibodies at antibodies-online.com

Showing 10 out of 208 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Goat Un-conjugated ELISA, WB ABIN334524 (0.3µg/ml) staining of Human Spleen lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. 100 μg Log in to see 6 to 7 Days
$326.89
Details
Human Mouse FITC FACS 0.1 mg Log in to see 6 to 8 Days
$566.50
Details
Human Rabbit Un-conjugated EIA, WB Western blot analysis of VTCN1 Antibody (Center) in T47D cell line lysates (35 µg/lane). VTCN1 (arrow) was detected using the purified Pab. 0.4 mL Log in to see 6 to 8 Days
$390.50
Details
Human Mouse Un-conjugated FACS, IHC (fro), IHC (p) 0.1 mg Log in to see 6 to 8 Days
$308.00
Details
Human Rabbit Un-conjugated FACS, IF (p), IHC (p), WB Formalin-fixed and paraffin embedded human thyroid carcinoma labeled Anti-B7H4 Polyclonal Antibody, Unconjugated (ABIN671736) at 1:200, followed by conjugation to the secondary antibody and DAB staining Formalin-fixed and paraffin embedded human gastric carcinoma labeled Anti-B7H4 Polyclonal Antibody, Unconjugated (ABIN671736) at 1:200, followed by conjugation to the secondary antibody and DAB staining 100 μL Log in to see 3 to 7 Days
$307.45
Details
Human Rabbit Un-conjugated IHC, ELISA, WB B7-H4 staining in human lung cancer. Paraffin-embedded human lung cancer tissue is stained with B7-H4 Antibody used at 1:200 dilution. 0.1 mg Log in to see 2 to 6 Days
$350.00
Details
Human Rabbit Un-conjugated ELISA, WB 0.1 mg Log in to see 2 to 3 Days
$340.00
Details
Human Goat Un-conjugated ELISA, WB Western Blot: B7-H4 Antibody [NBP1-06096] - (0.5ug/ml) staining of Human Pancrease lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. 0.1 mg Log in to see 7 to 9 Days
$408.19
Details
Human Mouse PE FACS 100 Tests Log in to see 6 to 8 Days
$434.50
Details
Human Rabbit Un-conjugated IHC, IHC (p) Immunohistochemistry: B7-H4 Antibody [NBP2-30536] - Immunohistochemical staining of human kidney shows strong membranous and cytoplasmic positivity in cells in tubules. 0.1 mL Log in to see 10 to 13 Days
$439.69
Details

VTCN1 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Mouse (Murine) , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Human , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,
Rat (Rattus) , , ,
,

, , , , , , , , , , , , , ,

Top referenced anti-VTCN1 Antibodies

  1. Human Polyclonal VTCN1 Primary Antibody for IHC, ELISA - ABIN1584048 : Basta, Galazka, Mach, Jozwicki, Walentowicz, Wicherek: The immunohistochemical analysis of RCAS1, HLA-G, and B7H4-positive macrophages in partial and complete hydatidiform mole in both applied therapeutic surgery and surgery followed by chemotherapy. in American journal of reproductive immunology (New York, N.Y. : 1989) 2011 (PubMed)
    Show all 4 references for 1584048

  2. Human Polyclonal VTCN1 Primary Antibody for EIA, WB - ABIN955537 : Xue, Luan, Gu, Wu, Zhang, Yu, Zhu, Wang, Dong, Geng, Zhang: The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. in Stem cells and development 2010 (PubMed)
    Show all 4 references for 955537

  3. Human Polyclonal VTCN1 Primary Antibody for IHC, IHC (p) - ABIN4282807 : Xu, Zhang, Zhang, Liu, Yin, Liu, Zhuo: Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer. in Oncology letters 2016 (PubMed)
    Show all 2 references for 4282807

  4. Human Polyclonal VTCN1 Primary Antibody for ELISA, WB - ABIN451629 : Krambeck, Thompson, Dong, Lohse, Park, Kuntz, Leibovich, Blute, Cheville, Kwon: B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. in Proceedings of the National Academy of Sciences of the United States of America 2006 (PubMed)

  5. Human Polyclonal VTCN1 Primary Antibody for FACS, IF (p) - ABIN671736 : Maskey, Li, Hu, Xu, Peng, Yu, Cao, Chen, Li, Yang: Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis. in Tumour biology 2014 (PubMed)

More Antibodies against VTCN1 Interaction Partners

Mouse (Murine) V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1) interaction partners

  1. Results highlight an importance of VTCN1 stabilization on cell surfaces for the restora (show APCS Antibodies)tion of altered balance of immune control during T1D.

  2. Ablation of B7-H3 (show CD276 Antibodies) but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer

  3. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.

  4. that B7x can modulate kidney damage in autoimmune diseases including lupus nephritis and anti-glomerular basement membrane disease

  5. B7-H4 can inhibit both antitumor T cells and protumor myeloid-derived suppressor cells (

  6. The endogenous expression of B7-H4 in donor beta cells from transgenic mice prolongs islet allograft survival, confirming the negative role of B7-H4 in regulating alloreactive T-cell responses.

  7. Local overexpression of B7x on pancreatic beta cells is sufficient to abolish CD8 (show CD8A Antibodies) T cell-induced diabetes.

  8. B7-H4 expression may influence the outcome of T-cell tumor cell interactions. Tumor-associated macrophage induced membrane-bound B7-H4 on lung cancer cell represents a novel mechanism by which lung cancer cells evade immune recognition and destruction.

  9. Overexpression of B7-H4 was shown in tumor infiltrated dendritic cells.

  10. Tissue-specific expression of B7x protects from CD4 (show CD4 Antibodies) T cell-mediated autoimmunity.

Human V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1) interaction partners

  1. B7-H4 is frequently expressed in ovarian serous carcinomas, especially high-grade serous carcinomas, and may represent a novel immunotherapeutic target in this cancer.

  2. While PD-L1 (show CD274 Antibodies) expression correlated with MSI (show MSI1 Antibodies) and high grade endometrial tumors, B7-H4 expression was independent of grade, histology and immune cell infiltration.

  3. the present review highlights the therapeutic potential of targeting B7-H4 in cancer

  4. Survival rate of the patients with higher B7-H4 expression was significantly worse than that of the patients with lower B7-H4 expression.

  5. Study provides evidence that B7-H4 expression is present in cervical intraepithelial neoplasia and cervical cancer patients and suggests its involvement in cervical cancer progression.

  6. this review shows that targeting the B7-H4 molecule may provide a promising potential for anticancer immunotherapy

  7. Higher expression of HBx and B7-H4 was correlated with tumor progression of hepatitis B virus-hepatocellular carcinoma, suggesting that B7-H4 may be involved in facilitating HBV-related hepatocarcinogenesis.

  8. Aberrant expression of B7-H4 has been identified to correlate with the TNM (show ODZ1 Antibodies) stage, differentiation degree and lymph node metastasis in patients with HCC (show FAM126A Antibodies).

  9. B7-H4 may be overexpressed on the majority of cells in the IDC (show LMNA Antibodies) microenvironment, including macrophages. In vitro experiments revealed that M1 and M2 cells expressed B7-H4. Compared with M1 cells, M2 cells exhibited significantly higher expression levels of B7-H4.

  10. wortmannin and rapamycin inhibit B7-H4-mediated tumor immunoresistance through regulating B7-H4 subcellular distribution. Taken together, these results suggest that PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) inhibitors might be used for adjuvant therapy aimed at inhibition of immune evasion.

VTCN1 Antigen Profile

Protein Summary

This gene encodes a protein belonging to the B7 costimulatory protein family. Proteins in this family are present on the surface of antigen-presenting cells and interact with ligand bound to receptors on the surface of T cells. Studies have shown that high levels of the encoded protein has been correlated with tumor progression. A pseudogene of this gene is located on chromosome 20. Multiple transcript variants encoding different isoforms have been found for this gene.

Gene names and symbols associated with VTCN1

  • V-set domain containing T cell activation inhibitor 1 (vtcn1) antibody
  • V-set domain containing T cell activation inhibitor 1 (VTCN1) antibody
  • V-set domain containing T cell activation inhibitor 1 (Vtcn1) antibody
  • B7-H4 antibody
  • B7h.5 antibody
  • B7H4 antibody
  • B7S1 antibody
  • B7X antibody
  • BC032925 antibody
  • PRO1291 antibody
  • RGD1311204 antibody
  • VCTN1 antibody

Protein level used designations for VTCN1

V-set domain-containing T-cell activation inhibitor 1 , V-set domain containing T cell activation inhibitor 1 , V-set domain containing T-cell activation inhibitor 1 , immune costimulatory protein B7-H4 , t cell costimulatory molecule B7x , B7 family member, H4 , B7 superfamily member 1 , T cell costimulatory molecule B7x , T-cell costimulatory molecule B7x

GENE ID SPECIES
379070 Xenopus laevis
418323 Gallus gallus
469433 Pan troglodytes
493551 Xenopus (Silurana) tropicalis
242122 Mus musculus
79679 Homo sapiens
295322 Rattus norvegicus
Selected quality suppliers for anti-VTCN1 (VTCN1) Antibodies
Did you look for something else?